Cardiff Oncology Inc. (CRDF) NASDAQ
$4.37 (0.13) (-2.89%)
Market Cap: $201.05M
As of 04/18/24 04:00 PM EDT. Market closed.
Cardiff Oncology Inc. (CRDF)
NASDAQ
$4.37
(0.13) (-2.89%)
Market Cap: $201.05M
As of 04/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary precision cancer monitoring® (pcm) technology in tumor genomics. trovagene has broad intellectual property and proprietary technology to measure circulating tumor dna (ctdna) in urine and blood to identify and quantify clinically actionable markers for ... read more
trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary precision cancer monitoring® (pcm) technology in tumor genomics. trovagene has broad intellectual property and proprietary technology to measure circulating tumor dna (ctdna) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. trovagene offers its pcm technology at its clia/cap – accredited laboratory and plans to continue to vertically integrate its pcm technology with precision cancer therapeutics. trovagene's lead therapeutic asset is pcm-075, an oral, investigational drug and a highly-selective polo-like kinase 1 (plk1) inhibitor for the treatment of acute myeloid leukemia (aml). among the four members of the plk family, plk1 is recognized to be the fundamental component for cell division to take place correctly. most importantly, plk1 is only expressed in dividing cells, wh read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Mark Erlander
Full Time Employees
43
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Mark Erlander
Full Time Employees
43
Address
11055 Flintkote Ave, California, San Diego, 92121.
PRICE CHART FOR CARDIFF ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.41
Previous Close
$4.50
Days Range
$4.26 - $4.48
52 week range
$0.94 - $6.38
Volume
832,218
Avg. Volume (30 days)
1,139,271
Market Cap
$201.05M
Dividend Yield
-
P/E
-
Shares Outstanding
44,677,169
Open
$4.41
Previous Close
$4.50
Days Range
$4.26 - $4.48
52 week range
$0.94 - $6.38
Volume
832,218
Avg. Volume (30 days)
1,139,271
Market Cap
$201.05M
Dividend Yield
-
P/E
-
Shares Outstanding
44,677,169
FINANCIAL STATEMENTS FOR CARDIFF ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CARDIFF ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| PACE GARY W | Director | Dec 19, 2023 | Buy | $1.37 | 30,000 | 41,100 | 697,761 | Dec 19, 2023, 06:39 PM |
| PACE GARY W | Director | Nov 10, 2023 | Buy | $0.98 | 22,950 | 22,491 | 667,761 | Nov 14, 2023, 04:24 PM |
| Erlander Mark | Chief Executive Officer | Nov 25, 2022 | Buy | $1.43 | 10,000 | 14,300 | 24,481 | Nov 29, 2022, 04:11 PM |
| Armitage James O | Director | Sep 16, 2022 | Buy | $1.56 | 13,000 | 20,233 | 13,000 | Oct 11, 2022, 04:22 PM |
| White Lale | Director | Sep 19, 2022 | Buy | $1.63 | 15,000 | 24,525 | 113,788 | Sep 20, 2022, 06:08 PM |
| TANNENBAUM RENEE P | Director | Sep 15, 2022 | Buy | $1.72 | 10,000 | 17,168 | 10,000 | Sep 19, 2022, 08:37 AM |
| PACE GARY W | Director | Sep 15, 2022 | Buy | $1.71 | 150,000 | 256,500 | 644,811 | Sep 19, 2022, 08:37 AM |
| Levine James E. | Chief Financial Officer | Sep 16, 2022 | Buy | $1.56 | 30,000 | 46,710 | 60,000 | Sep 19, 2022, 08:37 AM |
| White Lale | Director | Jul 05, 2022 | Option Exercise | $2.60 | 28,858 | 75,031 | 98,788 | Jul 06, 2022, 04:10 PM |
| PACE GARY W | Director | Sep 21, 2021 | Buy | $6.75 | 30,000 | 202,500 | 494,811 | Sep 22, 2021, 05:54 PM |
| Levine James E. | Chief Financial Officer | Sep 10, 2021 | Buy | $6.47 | 30,000 | 194,000 | 30,000 | Sep 13, 2021, 08:12 AM |
| Armitage James O | Director | Mar 19, 2021 | Buy | $10.82 | 4,000 | 43,271 | 14,490 | May 27, 2021, 05:14 PM |
| Markin Rodney S | Director | Mar 26, 2021 | Buy | $10.32 | 2,900 | 29,933 | 23,879 | Mar 29, 2021, 01:38 PM |
| PACE GARY W | Director | Mar 23, 2021 | Buy | $10.23 | 10,000 | 102,300 | 464,811 | Mar 24, 2021, 10:27 AM |
| JACOB GARY S | Director | Mar 23, 2021 | Buy | $10.42 | 2,370 | 24,689 | 21,922 | Mar 23, 2021, 03:57 PM |
| Kelemen Vicki | Exec. VP and COO | Mar 23, 2021 | Buy | $10.31 | 960 | 9,898 | 6,053 | Mar 23, 2021, 02:30 PM |
| Erlander Mark | Chief Executive Officer | Mar 23, 2021 | Buy | $10.34 | 965 | 9,980 | 14,481 | Mar 23, 2021, 12:24 PM |
| BRANCACCIO JOHN P | Director | Mar 22, 2021 | Buy | $10.95 | 3,000 | 32,850 | 12,260 | Mar 22, 2021, 06:35 PM |
| PACE GARY W | Director | Mar 18, 2021 | Buy | $10.55 | 3,000 | 31,660 | 454,811 | Mar 19, 2021, 11:34 AM |
| PACE GARY W | Director | Mar 04, 2021 | Buy | $9.27 | 1,500 | 13,898 | 451,811 | Mar 04, 2021, 08:46 PM |
| Kelemen Vicki | Exec. VP and COO | Nov 23, 2020 | Option Exercise | $2.48 | 35,321 | 87,596 | 40,375 | Nov 25, 2020, 04:02 PM |
| Kelemen Vicki | Exec. VP and COO | Nov 23, 2020 | Sale | $18.60 | 35,321 | 657,020 | 5,054 | Nov 25, 2020, 04:02 PM |
| PACE GARY W | Director | Sep 16, 2020 | Buy | $5.70 | 2,550 | 14,527 | 450,311 | Sep 17, 2020, 09:42 AM |
| Erlander Mark | Chief Executive Officer | May 14, 2020 | Buy | $1.43 | 6,993 | 10,000 | 13,369 | May 18, 2020, 04:17 PM |
| Markin Rodney S | Director | May 14, 2020 | Buy | $1.43 | 20,979 | 30,000 | 28,160 | May 18, 2020, 04:16 PM |
| BRANCACCIO JOHN P | Director | May 14, 2020 | Buy | $1.43 | 6,993 | 10,000 | 9,260 | May 18, 2020, 04:16 PM |
| JACOB GARY S | Director | May 14, 2020 | Buy | $1.43 | 17,483 | 25,001 | 19,552 | May 18, 2020, 04:16 PM |
| White Lale | Director | May 14, 2020 | Buy | $1.43 | 69,930 | 100,000 | 69,930 | May 18, 2020, 04:16 PM |
| Armitage James O | Director | May 14, 2020 | Buy | $1.43 | 10,490 | 15,001 | 10,490 | May 18, 2020, 04:15 PM |
| ADAMS THOMAS PHD | Director | May 14, 2020 | Buy | $1.43 | 13,986 | 20,000 | 18,875 | May 18, 2020, 04:15 PM |
| PACE GARY W | Director | May 11, 2020 | Buy | $1.34 | 447,761 | 600,000 | 447,761 | May 13, 2020, 04:16 PM |
| Markin Rodney S | Director | Jun 20, 2018 | Buy | $0.85 | 41,200 | 35,020 | 43,085 | Nov 09, 2018, 04:30 PM |
| Markin Rodney S | Director | Jun 20, 2018 | Buy | $0.85 | 41,200 | 35,020 | 63,810 | Jun 21, 2018, 04:30 PM |
| Tennant Stanley | Director | Jun 08, 2018 | Buy | $0.80 | 10,000 | 8,000 | 28,839 | Jun 13, 2018, 08:45 PM |
| BRANCACCIO JOHN P | Director | Jun 08, 2018 | Buy | $0.80 | 10,000 | 8,000 | 13,598 | Jun 13, 2018, 08:40 PM |
| BRANCACCIO JOHN P | Director | Jun 08, 2018 | Buy | $0.80 | 10,000 | 8,000 | 53,167 | Jun 11, 2018, 06:03 AM |
| Tennant Stanley | Director | Jun 08, 2018 | Buy | $0.80 | 10,000 | 8,000 | 236,061 | Jun 11, 2018, 06:03 AM |
| Tennant Stanley | Director | Sep 05, 2017 | Sale | $0.69 | 8,334 | 5,750 | 209,394 | Sep 06, 2017, 05:02 PM |
| Tennant Stanley | Director | Dec 19, 2016 | Buy | $2.10 | 10,000 | 21,000 | 217,728 | Dec 19, 2016, 04:51 PM |
| WELCH WILLIAM J | CEO | Dec 16, 2016 | Buy | $2.09 | 4,750 | 9,943 | 4,750 | Dec 19, 2016, 01:49 PM |
| Tennant Stanley | Director | Dec 16, 2016 | Buy | $2.00 | 14,966 | 29,932 | 207,728 | Dec 19, 2016, 06:04 AM |
| Erlander Mark | Chief Scientific Officer | Dec 14, 2016 | Buy | $2.08 | 5,000 | 10,375 | 5,000 | Dec 15, 2016, 05:00 PM |
| BRIDGER MANAGEMENT, LLC | Former 10% Owner | Nov 11, 2016 | Buy | $3.08 | 322,472 | 993,214 | 2,968,115 | Nov 15, 2016, 02:29 PM |
| ZANIBONI STEVE | Former CFO | Apr 21, 2016 | Option Exercise | $3.65 | 75,639 | 275,866 | 96,968 | Apr 22, 2016, 04:05 PM |
| Tennant Stanley | Director | Aug 12, 2015 | Buy | $6.06 | 160,000 | 969,600 | 192,762 | Aug 12, 2015, 04:50 PM |
| SCHUH ANTONIUS | CEO | Aug 12, 2015 | Buy | $5.45 | 20,000 | 109,000 | 20,000 | Aug 12, 2015, 04:35 PM |
| ZANIBONI STEVE | CFO | Aug 12, 2015 | Buy | $5.43 | 15,000 | 81,450 | 21,329 | Aug 12, 2015, 02:36 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Jul 17, 2015 | Buy | $8.75 | 140,000 | 1,225,000 | 3,290,587 | Jul 21, 2015, 05:27 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Apr 02, 2015 | Buy | $6.90 | 300,000 | 2,070,000 | 3,150,587 | Apr 06, 2015, 05:00 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Feb 27, 2015 | Buy | $5.62 | 79,343 | 445,908 | 2,850,587 | Feb 27, 2015, 07:21 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Feb 26, 2015 | Buy | $5.42 | 78,801 | 427,101 | 2,771,244 | Feb 27, 2015, 07:21 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Feb 25, 2015 | Buy | $5.12 | 105,142 | 538,327 | 2,692,443 | Feb 27, 2015, 07:21 PM |
| BRIDGER MANAGEMENT, LLC | 10% Owner | Feb 06, 2015 | Buy | $4.50 | 444,444 | 1,999,998 | 2,587,301 | Feb 10, 2015, 04:25 PM |
| ZANIBONI STEVE | CFO | Jun 09, 2014 | Buy | $3.95 | 6,329 | 25,000 | 6,329 | Jun 10, 2014, 03:59 PM |
| ADAMS THOMAS PHD | Director | Sep 03, 2013 | Sale | $8.64 | 4,200 | 36,288 | 326,486 | Sep 04, 2013, 05:09 PM |
| ADAMS THOMAS PHD | Director | Aug 30, 2013 | Sale | $8.06 | 15,000 | 120,900 | 330,686 | Sep 04, 2013, 05:09 PM |
| Tennant Stanley | Director | Nov 30, 2012 | Buy | $4.82 | 25,000 | 120,500 | 161,041 | Dec 03, 2012, 08:52 AM |
| CERRONE GABRIEL | Director | Aug 20, 2012 | Buy | $2.36 | 7,500 | 17,700 | 679,526 | Aug 20, 2012, 12:33 PM |
| CERRONE GABRIEL | Director | Aug 17, 2012 | Buy | $2.15 | 300 | 645 | 672,026 | Aug 20, 2012, 12:33 PM |
| CERRONE GABRIEL | Director | Aug 16, 2012 | Buy | $2.24 | 15,000 | 33,632 | 671,726 | Aug 17, 2012, 09:40 AM |
| CERRONE GABRIEL | Director | Apr 13, 2012 | Buy | $0.50 | 200,000 | 100,000 | 3,940,356 | Apr 16, 2012, 06:00 PM |
| Hunter Robert Merrill | 10% Owner | Apr 13, 2012 | Buy | $0.50 | 400,000 | 200,000 | 5,065,004 | Apr 16, 2012, 06:00 PM |
| Tennant Stanley | Director | Apr 13, 2012 | Buy | $0.50 | 100,000 | 50,000 | 816,246 | Apr 16, 2012, 05:59 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CARDIFF ONCOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 716,490 | 0.00003% | -0.15% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 424,106 | 0.00007% | 8.11% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 116,400 | 0.00027% | -24.42% | Other |
CHANGE IN SHARES OUTSTANDING FOR CARDIFF ONCOLOGY INC
STOCK BUYBACKS FOR CARDIFF ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0%
1Q
03/31/2023
0%
2Q
12/31/2022
0.34%
3Q
09/30/2022
3.10%
4Q
06/30/2022
3.17%
5Q
03/31/2022
3.34%
6Q
12/31/2021
10.00%
7Q
09/30/2021
12.96%
8Q
06/30/2021
15.26%
9Q
03/31/2021
20.22%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CARDIFF ONCOLOGY INC
LOADING...